Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently updated its advisory regarding illnesses linked to Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. As of June 17, 2024, …
FDA Warns Against Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies Amid Illness Outbreak Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has authorized the marketing of four menthol-flavored e-cigarette products by NJOY LLC. This decision marks the first time the FDA has …
FDA Authorizes Marketing of Four NJOY Menthol E-Cigarettes Read More
WASHINGTON, D.C. — This week, in a significant step for the medical world and hope for patients, the U.S. Food and Drug Administration expanded the approval of Elevidys, a gene …
FDA Broadens Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy Patients Read More
WASHINGTON, D.C. — On Thursday, U.S. Senators Bob Casey (D-PA) and Markwayne Mullin (R-OK) introduced the Creating Hope Reauthorization Act, a bipartisan effort aimed at encouraging pharmaceutical companies to develop …
Senate Leaders Push for Reauthorization of Program to Combat Rare Pediatric Diseases Read More
WASHINGTON, D.C. — The FDA has issued a warning letter to Dollar Tree Inc. following an investigation into lead and chromium contamination in apple cinnamon fruit puree pouches. This action …
FDA Warns Dollar Tree Over Lead Contamination in Fruit Puree Pouches Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) this week approved a new vaccine, Capvaxive, to combat invasive diseases and pneumonia caused by Streptococcus pneumoniae in adults. This approval …
FDA Approves New Pneumococcal Vaccine for Adults Read More
WASHINGTON, D.C. — The Food and Drug Administration’s (FDA) Center for Devices and Radiological Health recently published a blog titled “The Promise of Artificial Intelligence for Improving Health Care.” This …
FDA Highlights the Transformative Potential of Artificial Intelligence in Health Care Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary …
FDA Approves Keytruda Combination for Advanced Endometrial Cancer Read More WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) proposed a new order to address safety concerns related to over-the-counter (OTC) drugs containing acetaminophen. If finalized, this order …
FDA Proposes New Warning Label for Acetaminophen Products Read More
WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved durvalumab (Imfinzi, AstraZeneca UK Limited) for use with carboplatin plus paclitaxel followed by single-agent durvalumab. This approval targets …
FDA Approves New Treatment for Advanced Endometrial Cancer Read More